Synvisc

GUDID 05065026658043

MAPLESTONE DEVELOPMENTS LIMITED

Synovial fluid supplementation medium
Primary Device ID05065026658043
NIH Device Record Key8ace4216-0fa3-49e3-b671-d60670e3c6c2
Commercial Distribution StatusIn Commercial Distribution
Brand NameSynvisc
Version Model NumberOne
Company DUNS225683605
Company NameMAPLESTONE DEVELOPMENTS LIMITED
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numbertrue
Manufacturing Datetrue
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS105065026658043 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

MOZAcid, Hyaluronic, Intraarticular

Sterilization

Steralize Prior To Usefalse
Device Is Steriletrue

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2026-03-12
Device Publish Date2026-03-04

On-Brand Devices [Synvisc]

05065026658074N/A
05065026658043One

Trademark Results [Synvisc]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SYNVISC
SYNVISC
73597580 1418125 Live/Registered
BIOMATRIX, INC.
1986-05-08

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.